Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up.
Caraglia M, Correale P, Giannicola R, Staropoli N, Botta C, Pastina P, Nesci A, Caporlingua N, Francini E, Ridolfi L, Mini E, Roviello G, Ciliberto D, Agostino RM, Strangio A, Azzarello D, Nardone V, Falzea A, Cappabianca S, Bocchetti M, D'Arrigo G, Tripepi G, Tassone P, Addeo R, Giordano A, Pirtoli L, Francini G, Tagliaferri P. Caraglia M, et al. Among authors: correale p. Front Oncol. 2019 Nov 8;9:1102. doi: 10.3389/fonc.2019.01102. eCollection 2019. Front Oncol. 2019. PMID: 31781481 Free PMC article.
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects.
Tagliaferri P, Barile C, Caraglia M, Guarrasi R, Morelli D, Ricciardi B, Martignetti A, Librera MT, Matano E, Della Vecchia A, Catalano G, Famiani M, Palmieri G, Correale P, Bianco AR. Tagliaferri P, et al. Among authors: correale p. Am J Clin Oncol. 1998 Feb;21(1):48-53. doi: 10.1097/00000421-199802000-00011. Am J Clin Oncol. 1998. PMID: 9499257 Clinical Trial.
Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trial.
Correale P, Campoccia G, Tsang KY, Micheli L, Cusi MG, Sabatino M, Bruni G, Sestini S, Petrioli R, Pozzessere D, Marsili S, Fanetti G, Giorgi G, Francini G. Correale P, et al. Eur J Cancer. 2001 May;37(7):892-902. doi: 10.1016/s0959-8049(01)00063-6. Eur J Cancer. 2001. PMID: 11313178 Clinical Trial.
Weekly epirubicin in patients with hormone-resistant prostate cancer.
Petrioli R, Fiaschi AI, Pozzessere D, Messinese S, Sabatino M, Marsili S, Correale P, Manganelli A, Salvestrini F, Francini G. Petrioli R, et al. Among authors: correale p. Br J Cancer. 2002 Sep 23;87(7):720-5. doi: 10.1038/sj.bjc.6600525. Br J Cancer. 2002. PMID: 12232753 Free PMC article. Clinical Trial.
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcoma.
Petrioli R, Coratti A, Correale P, D'Aniello C, Grimaldi L, Tanzini G, Civitelli S, Marsili S, Messinese S, Marzocca G, Pirtoli L, Francini G. Petrioli R, et al. Among authors: correale p. Am J Clin Oncol. 2002 Oct;25(5):468-73. doi: 10.1097/00000421-200210000-00009. Am J Clin Oncol. 2002. PMID: 12393986 Clinical Trial.
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.
Petrioli R, Sabatino M, Fiaschi AI, Marsili S, Pozzessere D, Messinese S, Correale P, Civitelli S, Tanzini G, Tani F, De Martino A, Marzocca G, Lorenzi M, Giorgi G, Francini G. Petrioli R, et al. Among authors: correale p. Br J Cancer. 2004 Jan 26;90(2):306-9. doi: 10.1038/sj.bjc.6601521. Br J Cancer. 2004. PMID: 14735168 Free PMC article. Clinical Trial.
169 results